Increasing evidence indicates that Galectin-1 expression is dysregulated in cancer, and may contribute to tumor invasion and metastasis [17], angiogenesis [18], and protecting tumors from host immune responses [14, 19]. Here, LGALS1 is linked to neoplasm.